Key result
Acetylsalicylic acid inhibited IL-18-induced cardiac fibroblast migration by attenuating H2O2 generation, MMP9 activation, and RECK suppression.
Why the study?
Does acetylsalicylic acid inhibit IL-18-induced cardiac fibroblast migration in primary mouse cardiac fibroblasts?
Population
Primary mouse cardiac fibroblasts
Comparison
Acetylsalicylic acid at therapeutic concentrations vs Control (IL-18 stimulation without ASA)
Design
Preclinical
Authors
Loading...
Hypothesis-generating for acetylsalicylic acid in cardiac fibrosis; requires human validation before clinical consideration.
Does acetylsalicylic acid inhibit IL-18-induced cardiac fibroblast migration in primary mouse cardiac fibroblasts?
Acetylsalicylic acid inhibits IL-18-induced cardiac fibroblast migration by preventing RECK suppression and MMP9 activation, suggesting a potential protective mechanism against cardiac fibrosis.
Siddesha et al. (2013) studied Cardiac fibrosis. Acetylsalicylic acid (ASA) was evaluated on IL-18-induced cardiac fibroblast migration. Acetylsalicylic acid inhibited IL-18-induced cardiac fibroblast migration by attenuating H2O2 generation, MMP9 activation, and RECK suppression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: